Evaluation of an Internet-based intervention for patients with Long/Post-COVID following acute COVID-19 infection: A Cohort Study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032668

Enrollment

Registered

2023-09-13

Start date

2023-09-18

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U09.9

Interventions

Group 1: All participnats of the first study that registered for using our new app ReCOVer receive an invitation via e-mail to participate in another study (including information for participants and

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - legal age - fluent in german - written confirmation of the Long/Post-COVID diagnosis by a doctor - informed consent to take part in our first epidemiological study about Long/Post-COVID (SR+BO-67022023)

Exclusion criteria

Exclusion criteria: - underage - current psychotic disorder - current addiction disorder - functional status after Long/Post-COVID below 2 - missing confirmation of the Long/Post-COVID diagnosis by a doctor

Design outcomes

Primary

Measure	Time frame
Differences in quality of life (EQ-5D-5L) between pre- and post-test.	—

Secondary

Measure	Time frame
1. Differences in psychological symptoms (PHQ-D) between pre- and post-test. 2. Minimally Clinically Important Difference in quality of life of at least 15% of the range of the EQ-5D-5L. 3. Minimally Clinically Important Difference in psychological symptoms of at least 15% of the subscales of the PHQ-D. 4. Acceptance, assessed by self-generated questionnaires to evaluate the single chapters and the intervention. 5. Target group/ range of influence, assessed by a self-generated questionnaire about sociodemographic variables. 6. Adherence, assessed by the number of finished chapters of the intervention.	—

Measure

Time frame

1. Differences in psychological symptoms (PHQ-D) between pre- and post-test. 2. Minimally Clinically Important Difference in quality of life of at least 15% of the range of the EQ-5D-5L. 3. Minimally Clinically Important Difference in psychological symptoms of at least 15% of the subscales of the PHQ-D. 4. Acceptance, assessed by self-generated questionnaires to evaluate the single chapters and the intervention. 5. Target group/ range of influence, assessed by a self-generated questionnaire about sociodemographic variables. 6. Adherence, assessed by the number of finished chapters of the intervention.

—

Countries

Germany

Contacts

Public ContactCorinna Jacobi

TU Dresden

corinna.jacobi@tu-dresden.de+4935146337469

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026